Avanos Medical authorizes new $25M share repurchase program

AVANOS MEDICAL, INC.

Board approved up to $25.0 million in common stock repurchases over one year.
Repurchases to be made at management's discretion on open market or via private transactions.
Program will not commence until at least one full trading day after release of any material non-public info.
Company is not obligated to repurchase any specific amount; program may be suspended or discontinued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.